Press releases
- CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- CareDx to Report First Quarter 2024 Financial Results
- CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
- CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
- CareDx Appoints Bryan Riggsbee to Its Board of Directors
- CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
- CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
- CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
- CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
More ▼
Key statistics
On Friday, CareDx Inc (1K9:DEU) closed at 9.10, -23.56% below its 52-week high of 11.90, set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.61 |
---|---|
High | 9.21 |
Low | 8.56 |
Bid | 8.94 |
Offer | 9.09 |
Previous close | 8.59 |
Average volume | 60.20 |
---|---|
Shares outstanding | 51.78m |
Free float | 49.34m |
P/E (TTM) | -- |
Market cap | 503.29m USD |
EPS (TTM) | -3.55 USD |
Data delayed at least 15 minutes, as of May 03 2024.
More ▼